ADL
REGN icon

Asset Dedication LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Asset Dedication LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$12.1K – 1218
2025
Q1 		$12.1K Buy
19
+3
+19% +$2.06K ﹤0.01% 733
2024
Q4 		$11.4K Buy
16
+1
+7% +$839 ﹤0.01% 749
2024
Q3 		$15.8K Hold
15
– – ﹤0.01% 737
2024
Q2 		$15.8K Hold
15
– – ﹤0.01% 728
2024
Q1 		$14K Hold
15
– – ﹤0.01% 645
2023
Q4 		$13K Hold
15
– – ﹤0.01% 643
2023
Q3 		$12K Buy
+15
New +$11.8K ﹤0.01% 658
2022
Q1 		– Sell
-17
Closed -$11K – 1043
2021
Q4 		$11K Hold
17
– – ﹤0.01% 638
2021
Q3 		$10K Buy
+17
New +$10.6K ﹤0.01% 699
2020
Q3 		– Sell
-200
Closed -$125K – 780
2020
Q2 		$125K Buy
+200
New +$114K 0.03% 241
2019
Q4 		– Sell
-17
Closed -$5K – 812
2019
Q3 		$5K Sell
17
-21
-55% -$6.21K ﹤0.01% 509
2019
Q2 		$14K Sell
38
-5
-12% -$1.67K ﹤0.01% 398
2019
Q1 		$16K Hold
43
– – 0.01% 400
2018
Q4 		$16K Sell
43
-44
-51% -$16.1K 0.01% 384
2018
Q3 		$32K Hold
87
– – 0.01% 301
2018
Q2 		$32K Sell
87
-18
-17% -$5.63K 0.01% 317
2018
Q1 		$39K Sell
105
-32
-23% -$11.1K 0.02% 257
2017
Q4 		$50K Sell
137
-475
-78% -$192K 0.02% 243
2017
Q3 		$275K Hold
612
– – 0.13% 117
2017
Q2 		$290K Hold
612
– – 0.15% 120
2017
Q1 		$228K Sell
612
-8
-1% -$2.96K 0.12% 129
2016
Q4 		$227K Buy
620
+545
+727% +$207K 0.13% 128
2016
Q3 		$31K Buy
75
+3
+4% +$1.2K 0.02% 223
2016
Q2 		$23K Hold
72
– – 0.02% 228
2016
Q1 		$26K Sell
72
-18
-20% -$7.42K 0.02% 225
2015
Q4 		$49K Buy
+90
New +$48.8K 0.03% 237

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Asset Dedication LLC's REGN Position: Q2 2025 in Review

Asset Dedication LLC sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 19 shares — an estimated $12.1K sold.

Asset Dedication LLC first reported a position in REGN in Q4 2015 and held it in 26 quarters. The position peaked at $290K in Q2 2017. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Asset Dedication LLC reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 19 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $12.1K.
  • Asset Dedication LLC first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 26 quarters.
  • Asset Dedication LLC's Regeneron Pharmaceuticals position peaked at $290K in Q2 2017.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Asset Dedication LLC's 13F filing for Q2 2025, filed 19 Aug 2025.